image credit: Flickr

Boston Scientific device may replace anticoagulants in heart surgery

WATCHMAN is a permanent implant for closing the left atrial appendage in the heart to mitigate the stroke risk.

The new device has a fully enclosed and rounded frame to enable implantation flexibility for customising the placement. Physicians will be able to fully recapture and reposition the device during a procedure.

During the randomised, controlled OPTION trial, the safety and effectiveness of the new WATCHMAN FLX implant will be compared to first-line oral anticoagulants (OAC) such as direct oral anticoagulants (DOAC) and warfarin.